StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research note published on Sunday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of NASDAQ GLMD opened at $0.37 on Friday. The company’s fifty day moving average price is $0.39 and its […]
Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD – Get Free Report) was the target of a large decrease in short interest in January. As of January 15th, there was short interest totalling 55,100 shares, a decrease of 9.7% from the December 31st total of 61,000 shares. Based on an average trading volume of 175,200 shares, the days-to-cover ratio […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Galmed Pharmaceuticals stock opened at $0.45 on Wednesday. Galmed Pharmaceuticals has a fifty-two week low of $0.26 and a fifty-two week high […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a report published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance GLMD stock opened at $0.46 on Tuesday. The firm has a market cap of $764,400.00, a price-to-earnings ratio of -0.12 and […]
StockNews.com initiated coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Trading Up 5.8 % GLMD stock opened at $0.40 on Monday. The stock has a market capitalization of $672,000.00, a […]